These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8519610)

  • 1. Autoantibodies in systemic lupus erythematosus.
    Elkon K
    Curr Opin Rheumatol; 1995 Sep; 7(5):384-8. PubMed ID: 8519610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.
    Yaniv G; Twig G; Shor DB; Furer A; Sherer Y; Mozes O; Komisar O; Slonimsky E; Klang E; Lotan E; Welt M; Marai I; Shina A; Amital H; Shoenfeld Y
    Autoimmun Rev; 2015 Jan; 14(1):75-9. PubMed ID: 25449682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of antinuclear antibodies in systemic lupus erythematosus and related diseases.
    Tan EM
    Adv Dent Res; 1996 Apr; 10(1):44-6. PubMed ID: 8934923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit anti-HMG-17 antibodies recognize similar epitopes on the HMG-17 molecule as lupus autoantibodies. Relation with histone H1 defined epitopes.
    Boumba VA; Seferiadis K
    J Pept Sci; 2002 Dec; 8(12):683-94. PubMed ID: 12523645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells biology in systemic lupus erythematosus-from bench to bedside.
    Zhao L; Ye Y; Zhang X
    Sci China Life Sci; 2015 Nov; 58(11):1111-25. PubMed ID: 26563177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases.
    Maddison P; Mogavero H; Provost TT; Reichlin M
    J Rheumatol; 1979; 6(2):189-95. PubMed ID: 88520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.
    Moulton VR; Tsokos GC
    J Clin Invest; 2015 Jun; 125(6):2220-7. PubMed ID: 25961450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective B cell tolerance checkpoints in systemic lupus erythematosus.
    Yurasov S; Wardemann H; Hammersen J; Tsuiji M; Meffre E; Pascual V; Nussenzweig MC
    J Exp Med; 2005 Mar; 201(5):703-11. PubMed ID: 15738055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus.
    Nozawa K; Doe K; Uomori K; Sekigawa I; Takasaki Y; Yamaji K; Tamura N
    Autoimmunity; 2017 Jun; 50(4):241-246. PubMed ID: 28553742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Engelbertsen D; Wigren M; Gustafsson JT; Gunnarsson I; Elvin K; Jensen-Urstad K; Fredrikson GN; Nilsson J
    Clin Exp Immunol; 2015 Sep; 181(3):417-26. PubMed ID: 25959453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent expression of autoantibodies in systemic lupus erythematosus.
    McCarty GA; Rice JR; Bembe ML; Pisetsky DS
    J Rheumatol; 1982; 9(5):691-5. PubMed ID: 6983576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do naturally occurring autoantibodies participate in the constitution of the pathological B-cell repertoire in systemic lupus erythematosus?
    Gilbert D; Brard F; Jovelin F; Tron F
    J Autoimmun; 1996 Apr; 9(2):247-57. PubMed ID: 8738970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and humoral recognition of the products of cell death: differential antigenicity and immunogenicity in lupus.
    Arora P; Malik M; Sachdeva R; Saxena L; Das J; Ramachandran VG; Pal R
    Clin Exp Immunol; 2017 Mar; 187(3):353-368. PubMed ID: 27783388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interferon-alpha signature of systemic lupus erythematosus.
    Obermoser G; Pascual V
    Lupus; 2010 Aug; 19(9):1012-9. PubMed ID: 20693194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mimicry in systemic lupus erythematosus.
    Agmon-Levin N; Blank M; Paz Z; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1181-5. PubMed ID: 19880565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The busy life of regulatory T cells in systemic lupus erythematosus.
    La Cava A
    Discov Med; 2009 Jun; 8(40):13-7. PubMed ID: 19772836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular, metabolic and immune evidence suggest that systemic autoimmune disease is antigen-mediated.
    Benke PJ
    Med Hypotheses; 1996 Nov; 47(5):337-46. PubMed ID: 8951798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus.
    Levine JS; Subang R; Nasr SH; Fournier S; Lajoie G; Wither J; Rauch J
    J Immunol; 2006 Nov; 177(9):6504-16. PubMed ID: 17056583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies.
    van Bavel CC; Dieker J; Muller S; Briand JP; Monestier M; Berden JH; van der Vlag J
    Mol Immunol; 2009 Dec; 47(2-3):511-6. PubMed ID: 19747733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.